- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07755280
Predictors of Sleep Quality in Patients Undergoing Open-Heart Surgery
August 5, 2026 updated by: Ezgi Arslan, Aydin Adnan Menderes University
Predictors of Sleep Quality in Patients Undergoing Open-Heart Surgery: A Hierarchical Regression Analysis
Sleep quality is a complex and multidimensional phenomenon shaped by the interaction of patient characteristics, symptom burden, and environmental factors specific to the intensive care unit environment.
Despite this multidimensional nature, studies identifying predictors of sleep quality in intensive care units after cardiac surgery are limited.
Study Overview
Status
Completed
Conditions
Detailed Description
Sleep is a fundamental biological process necessary for maintaining physiological homeostasis, supporting immune function, and promoting healing.
Sleep quality is a multidimensional construct influenced by individual characteristics such as age and body mass index, as well as psychological factors like stress and anxiety, and environmental factors such as noise, light, lack of privacy, and care practices.
However, patients in intensive care units often experience poor sleep quality, characterized by reduced sleep duration, fragmented sleep, prolonged sleep latency, and frequent awakenings.
Poor sleep quality in intensive care units leads to a higher incidence of delirium and atrial fibrillation complications in patients during the postoperative period, delayed recovery time, negative impact on immune function, and prolonged stay in the intensive care unit.
Open heart surgery is a frequently performed operation in ischemic and non-ischemic heart diseases (valve diseases, aortic stenosis, and atrial septal defect, etc.) that requires close monitoring of patients in an intensive care environment after surgery.
Following these surgeries, physiological issues such as pain, surgical wound problems, fatigue, dyspnea, and sleep problems commonly experienced by patients in intensive care settings, and psychological issues such as anxiety, stress, fear of death negatively affect sleep quality.
In addition, individual characteristics such as age and body mass index (BMI) can also affect sleep quality in this patient population.
Poor sleep quality in intensive care units is a commonly reported problem by patients, but due to its multifaceted nature, it is often not effectively managed.
Although previous studies have reported the prevalence of sleep disorders in intensive care patients, most studies have failed to adopt a comprehensive and multifactorial approach that examines the variables affecting sleep quality individually.
This situation highlights the need for studies using multivariate analytical methods to identify independent predictors of sleep quality.
The aim of this study is to examine the predictors of sleep quality in patients undergoing open heart surgery and admitted to the cardiovascular surgery intensive care unit, using a multivariate approach.
Study Type
Observational
Enrollment (Actual)
157
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zafer Mahallesi
-
Aydin, Zafer Mahallesi, Turkey (Türkiye), 09010
- Aydın Adnan Menderes University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients admitted to the cardiovascular intensive care unit after open heart surgery
Description
Inclusion Criteria:
- ability to understand and speak Turkish,
- willingness to participate in the study,
- having spent at least 24 hours in the intensive care unit, and
- having the cognitive ability to understand and answer questions.
Exclusion Criteria:
- having taken narcotic or sedative drugs within the last 48 hours,
- having a history of chronic diseases that can cause sleep problems such as Chronic Obstructive Pulmonary Disease or sleep apnea,
- having a psychiatric illness diagnosed by a physician,
- having a visual or hearing impairment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain
Time Frame: At least 24 hours after admission to the intensive care unit
|
Assessed wit Visual Analog Scale.
his scale is a unidimensional, self-report instrument measuring 10 cm in length.
The lower end corresponds to a score of 0, labeled 'no pain,' while the upper end corresponds to a score of 10, labeled 'unbearable pain.' Higher scores on the scale indicate greater severity of pain as reported by the patient.
|
At least 24 hours after admission to the intensive care unit
|
|
Sleep quality
Time Frame: At least 24 hours after admission to the intensive care unit
|
Assessed with Richard- Campbell Sleep Questionnaire. he scale consists of 6 items assessing sleep quality, nocturnal sleep depth, frequency of awakening, ambient noise level, time spent awake, and sleep onset latency.
Each item is rated on a visual analog scale ranging from 0 to 100.
The total score obtained from the scale is divided by the number of items to calculate the scale score.
A scale score between 0 and 25 is interpreted as very poor sleep, while a score between 76 and 100 is interpreted as very good sleep.
|
At least 24 hours after admission to the intensive care unit
|
|
Fatigue
Time Frame: At least 24 hours after admission to the intensive care unit
|
Assessed wit Visual Analog Scale.
his scale is a unidimensional, self-report instrument measuring 10 cm in length.
The lower end corresponds to a score of 0, labeled 'no fatigue,' while the upper end corresponds to a score of 10, labeled 'unbearable fatigue.'
Higher scores on the scale indicate greater severity of fatigue as reported by the patient.
|
At least 24 hours after admission to the intensive care unit
|
|
Environmental Stressors
Time Frame: At least 24 hours after admission to the intensive care unit
|
Assessed with Intensive Care Unit Environmental Stressors Scale.
The scale is of a 4-point Likert type and consists of 42 items.
The minimum possible score is 42 and the maximum is 168.
Higher scores are interpreted as indicating a greater degree of being affected by environmental stressors.
|
At least 24 hours after admission to the intensive care unit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2025
Primary Completion (Actual)
March 15, 2026
Study Completion (Actual)
May 15, 2026
Study Registration Dates
First Submitted
August 5, 2026
First Submitted That Met QC Criteria
August 5, 2026
First Posted (Actual)
August 10, 2026
Study Record Updates
Last Update Posted (Actual)
August 10, 2026
Last Update Submitted That Met QC Criteria
August 5, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Predictors of Sleep Quality
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
IPD Sharing Time Frame
12 months after publication
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.